A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 589-594

  Nakagawa, S ^a   Yoshikawa, H ^a   Kimura, M ^a   Kawana, K ^a   Matsumoto, K ^a   Onda, T ^a   Kino, N ^a   Yamada, M ^a   Yasugi, T ^a   Taketani, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carcinogenesis; Cervical carcinoma; Cervical intraepithelial neoplasia; FHIT gene expression; Human papillomavirus; Squamous cell carcinoma

Indexed keywords

COMPLEMENTARY DNA;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; INCIDENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME FRAGILITY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTIDINE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 0032903152     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690093     Document Type: Article

References (21)

1. Choo K-B and Chong KY (1993) Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 193: 1042-1046
2. Crook T and Vousden KH (1992) Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 11: 3935-3940
3. Crook T, Wrede D and Vousden KH (1991) p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6: 873-875
4. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF and Minna JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and prencoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57: 2256-2267
5. Fujita M, Inoue M, Tanizawa O, Iwamoto S and Enomoto T (1992) Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52: 5323-5328
6. Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP and Harris CC (1997) FHIT mutations in human primary gastric cancer. Cancer Res 57: 1435-1437
7. Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JTC, Kim Y-T, Mok JE, Munoz N, Bosch FX, Shah K and Cho KR (1997) Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57: 4692-4698
8. Helland A, Holm R, Kristensen G, Laern J, Kaern J, Karlsen F, Trope C, Nesland JM and Borresen AL (1993) Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol 171: 105-114
9. Hendricks DT, Taylor R, Reed M and Birrer MJ (1997) FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res 57: 2112-2115
10. Huibregtse JM, Scheffner M and Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129-4135
11. Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK and Hampton GM (1997) High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 57: 4082-4090
12. Mao L, Fan YH, Lotan R and Hong WK (1996) Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 57: 5128-5131
13. Miwa K, Miyamoto S, Imamura T, Nishida M, Yoshikawa Y, Nagata Y and Wake N (1995) The role of p53 inactivation in human cervical cell carcinoma development. Br J Cancer 71: 219-226
14. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E and Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099-4105
15. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Hebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597
16. Seheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136
17. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti Ma, Ohta M, Huebner K and Croce CM (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85: 17-26
18. Werness BA, Levine AJ and Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79
19. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI and Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5: 187-195
20. Wistuba I, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD and Gazdar AF (1997) Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57: 3154-3158
21. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H and Iwamoto A (1991) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82: 524-531